Literature DB >> 16944935

Phyloproteomics: what phylogenetic analysis reveals about serum proteomics.

Mones Abu-Asab1, Mohamed Chaouchi, Hakima Amri.   

Abstract

Phyloproteomics is a novel analytical tool that solves the issue of comparability between proteomic analyses, utilizes a total spectrum-parsing algorithm, and produces biologically meaningful classification of specimens. Phyloproteomics employs two algorithms: a new parsing algorithm (UNIPAL) and a phylogenetic algorithm (MIX). By outgroup comparison, the parsing algorithm identifies novel or vanished MS peaks and peaks signifying up or down regulated proteins and scores them as derived or ancestral. The phylogenetic algorithm uses the latter scores to produce a biologically meaningful classification of the specimens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944935      PMCID: PMC2270414          DOI: 10.1021/pr0504485

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  23 in total

Review 1.  Proteomics in early detection of cancer.

Authors:  P R Srinivas; S Srivastava; S Hanash; G L Wright
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

Review 2.  The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

Authors:  D C Chung
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

3.  SELDI-TOF MS for diagnostic proteomics.

Authors:  Haleem J Issaq; Thomas P Conrads; DaRue A Prieto; Radhakrishna Tirumalai; Timothy D Veenstra
Journal:  Anal Chem       Date:  2003-04-01       Impact factor: 6.986

Review 4.  Mass spectrometry-based clinical proteomics.

Authors:  Wolfgang Pusch; Mark T Flocco; Sau-Mei Leung; Herbert Thiele; Markus Kostrzewa
Journal:  Pharmacogenomics       Date:  2003-07       Impact factor: 2.533

Review 5.  Significance of multiple mutations in cancer.

Authors:  K R Loeb; L A Loeb
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

6.  Serum proteomic patterns for detection of prostate cancer.

Authors:  Emanuel F Petricoin; David K Ornstein; Cloud P Paweletz; Ali Ardekani; Paul S Hackett; Ben A Hitt; Alfredo Velassco; Christian Trucco; Laura Wiegand; Kamillah Wood; Charles B Simone; Peter J Levine; W Marston Linehan; Michael R Emmert-Buck; Seth M Steinberg; Elise C Kohn; Lance A Liotta
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

7.  The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.

Authors:  N Volkan Adsay; Kambiz Merati; Aleodor Andea; Fazlul Sarkar; Ralph H Hruban; Robb E Wilentz; Micheal Goggins; Christine Iocobuzio-Donahue; Daniel S Longnecker; David S Klimstra
Journal:  Mod Pathol       Date:  2002-10       Impact factor: 7.842

8.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

Review 9.  Molecular genetic analysis of deep-seated glioblastomas.

Authors:  Yutaka Hayashi; Junkoh Yamashita; Takuya Watanabe
Journal:  Cancer Genet Cytogenet       Date:  2004-08

10.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Authors:  Bao-Ling Adam; Yinsheng Qu; John W Davis; Michael D Ward; Mary Ann Clements; Lisa H Cazares; O John Semmes; Paul F Schellhammer; Yutaka Yasui; Ziding Feng; George L Wright
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

View more
  11 in total

1.  Evolutionary medicine: A meaningful connection between omics, disease, and treatment.

Authors:  Mones Abu-Asab; Mohamed Chaouchi; Hakima Amri
Journal:  Proteomics Clin Appl       Date:  2008-02       Impact factor: 3.494

2.  A Systems Biology Interpretation of Array Comparative Genomic Hybridization (aCGH) Data through Phylogenetics.

Authors:  Ayman N Abunimer; Jose Salazar; David P Noursi; Mones S Abu-Asab
Journal:  OMICS       Date:  2016-03

3.  Identifying early events of gene expression in breast cancer with systems biology phylogenetics.

Authors:  M S Abu-Asab; N Abu-Asab; C A Loffredo; R Clarke; H Amri
Journal:  Cytogenet Genome Res       Date:  2013-04-03       Impact factor: 1.636

4.  Biomarkers in the age of omics: time for a systems biology approach.

Authors:  Mones S Abu-Asab; Mohamed Chaouchi; Salvatore Alesci; Susana Galli; Majid Laassri; Amrita K Cheema; Fouad Atouf; John VanMeter; Hakima Amri
Journal:  OMICS       Date:  2011-02-14

5.  Analyzing heterogeneous complexity in complementary and alternative medicine research: a systems biology solution via parsimony phylogenetics.

Authors:  Mones Abu-Asab; Mary Koithan; Joan Shaver; Hakima Amri
Journal:  Forsch Komplementmed       Date:  2012-01-20

6.  Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens.

Authors:  Mones S Abu-Asab; Mohamed Chaouchi; Hakima Amri
Journal:  OMICS       Date:  2008-09

7.  Study of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis.

Authors:  Sinem Nalbantoglu; Mones Abu-Asab; Ming Tan; Xuemin Zhang; Ling Cai; Hakima Amri
Journal:  OMICS       Date:  2016-07

8.  The great opportunity: Evolutionary applications to medicine and public health.

Authors:  Randolph M Nesse; Stephen C Stearns
Journal:  Evol Appl       Date:  2008-02       Impact factor: 5.183

9.  Endometriosis gene expression heterogeneity and biosignature: a phylogenetic analysis.

Authors:  Mones Abu-Asab; Ming Zhang; Dennis Amini; Nihad Abu-Asab; Hakima Amri
Journal:  Obstet Gynecol Int       Date:  2011-12-13

10.  Systems Biology Profiling of AMD on the Basis of Gene Expression.

Authors:  Mones S Abu-Asab; Jose Salazar; Jingsheng Tuo; Chi-Chao Chan
Journal:  J Ophthalmol       Date:  2013-11-14       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.